Staphylococcal Resistance Patterns, blaZ and SCC mec Cassette Genes in the Nasopharyngeal Microbiota of Pregnant Women

Int J Mol Sci. 2023 Apr 28;24(9):7980. doi: 10.3390/ijms24097980.

Abstract

Antimicrobial resistance in Staphylococcus spp. colonising the nasopharynx can create risk factors of therapeutic treatment failure or prophylaxis in pregnant women. Resistance is mostly encoded on plasmids (e.g., blaZ gene for penicillinase synthesis) or chromosomes (e.g., mecA and mecC for methicillin resistance). The mecA gene is part of the chromosomal mec gene cassette (SCCmec), which is also located on the plasmid. The disc diffusion method for the selected drugs (beta-lactams, fluoroquinolones, streptogramins, aminoglicosides, macrolides, oxasolidinones, tetracyclines and other groups) was used. PCR for blaZ, mecA and mecC genes and SCCmec cassette detection and typing were performed. S. aureus (54.4%) and S. epidermidis (27.9%) were the most prevalent and showed the highest diversity of resistance profiles. The blaZ, mecA and mecC genes were reported in 95.6%, 20.6% and 1.5% of isolates, respectively. The highest resistance was found to beta-lactams, commonly used during pregnancy. Resistance to a variety of antimicrobials, including benzylpenicillin resistance in blaZ-positive isolates, and the existence of a very high diversity of SCCmec cassette structures in all staphylococci selected from the nasopharyngeal microbiota of pregnant women were observed for the first time. Knowledge of the prevalence of antimicrobial-resistant staphylococci in the nasopharynx of pregnant women may be important for the appropriate treatment or prophylaxis of this group of patients.

Keywords: SSCmec cassette typing; blaZ gene; nasopharyngeal microbiota; pregnancy; pregnant women; staphylococci.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Bacterial Proteins / genetics
  • Female
  • Humans
  • Methicillin-Resistant Staphylococcus aureus* / genetics
  • Microbial Sensitivity Tests
  • Pregnancy
  • Pregnant Women
  • Staphylococcal Infections* / drug therapy
  • Staphylococcal Infections* / epidemiology
  • Staphylococcal Infections* / genetics
  • Staphylococcus / genetics
  • Staphylococcus aureus / genetics
  • Staphylococcus epidermidis
  • beta-Lactams

Substances

  • Anti-Bacterial Agents
  • beta-Lactams
  • Bacterial Proteins

Grants and funding

This research received no external funding. This study was supported by the Medical University of Lublin, Poland (grant no. DS31).